14. Neuropeptidomics

  1. Michael L. Gross3,
  2. Guodong Chen4 and
  3. Birendra N. Pramanik5
  1. Jonathan V. Sweedler1,
  2. Fang Xie2 and
  3. Adriana Bora1

Published Online: 23 SEP 2011

DOI: 10.1002/9781118116555.ch14

Protein and Peptide Mass Spectrometry in Drug Discovery

Protein and Peptide Mass Spectrometry in Drug Discovery

How to Cite

Sweedler, J. V., Xie, F. and Bora, A. (2011) Neuropeptidomics, in Protein and Peptide Mass Spectrometry in Drug Discovery (eds M. L. Gross, G. Chen and B. N. Pramanik), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118116555.ch14

Editor Information

  1. 3

    Washington University, St. Louis, MO, USA

  2. 4

    Bristol-Myers Squibb, Princeton, NJ, USA

  3. 5

    Merck Research Laboratories, Kenilworth, NJ, USA

Author Information

  1. 1

    University of Illinois, Urbana, IL, USA

  2. 2

    Pacific Northwest National Laboratory, Richland, WA, USA

Publication History

  1. Published Online: 23 SEP 2011
  2. Published Print: 21 OCT 2011

ISBN Information

Print ISBN: 9780470258170

Online ISBN: 9781118116555

SEARCH

Keywords:

  • neuropeptidomics;
  • peptide measurement;
  • peptide characterization

Summary

This chapter contains sections titled:

  • Introduction

  • Neuropeptidomics: Characterizing Peptides in the Brain

  • Sample Preparation for Mass Spectrometry

  • Separations

  • Peptide Characterization via Mass Spectrometry

  • Conclusions

  • Future Perspectives

  • Acknowledgments

  • References